Acute Myeloid Leukemia /Features

ISAL 2017: Developments in acute leukemias

The International Symposium on Acute Leukemias (ISAL) 2017 was, as always, filled with data, scientific developments and debate. To capture…

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia
3 years

Innovative Medicines Initiative approves €40 million HARMONY project for better care of patients with hematologic malignancies

The Innovative Medicines Initiative (IMI) has approved HARMONY, a project that aims to foster better access and care for patients…

Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Multiple Myeloma Myelodysplastic Syndromes Non-Hodgkin Lymphoma
3 years

New tyrosine kinase inhibitor shows promise

MRX-2843 is a tyrosine kinase inhibitor that targets the receptor tyrosine kinases MERTK and FLT3. Both MERTK and FLT3 are…

Acute Myeloid Leukemia
4 years

Cytarabine-daunorubicin liposome for injection: a potential new standard of care for elderly patients

The Phase III trial of a novel formulation of cytarabine-daunorubicin encapsulated in a liposome for injection, also referred to as…

Acute Myeloid Leukemia
4 years
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals